Long-term follow-up after endoscopic resection for superficial esophageal squamous cell carcinoma: a multicenter Western study.


Journal

Endoscopy
ISSN: 1438-8812
Titre abrégé: Endoscopy
Pays: Germany
ID NLM: 0215166

Informations de publication

Date de publication:
04 2019
Historique:
pubmed: 28 9 2018
medline: 18 4 2020
entrez: 28 9 2018
Statut: ppublish

Résumé

Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are the first-line treatments for superficial esophageal squamous cell carcinoma (SCC). This study aimed to compare long-term clinical outcome and oncological clearance between EMR and ESD for the treatment of superficial esophageal SCC. We conducted a retrospective multicenter study in five French tertiary care hospitals. Patients treated by EMR or ESD for histologically proven superficial esophageal SCC were included consecutively. Resection was performed for 148 tumors (80 EMR, 68 ESD) in 132 patients. The curative resection rate was 21.3 % in the EMR group and 73.5 % in the ESD group ( Endoscopic resection of superficial esophageal SCC was safe and efficient. Because it was associated with an increased recurrence-free survival rate, ESD should be preferred over EMR. For tumors with infiltration depths ≥ m3, chemoradiotherapy reduced the risk of nodal or distal metastasis.

Sections du résumé

BACKGROUND
Endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) are the first-line treatments for superficial esophageal squamous cell carcinoma (SCC). This study aimed to compare long-term clinical outcome and oncological clearance between EMR and ESD for the treatment of superficial esophageal SCC.
METHODS
We conducted a retrospective multicenter study in five French tertiary care hospitals. Patients treated by EMR or ESD for histologically proven superficial esophageal SCC were included consecutively.
RESULTS
Resection was performed for 148 tumors (80 EMR, 68 ESD) in 132 patients. The curative resection rate was 21.3 % in the EMR group and 73.5 % in the ESD group (
CONCLUSION
Endoscopic resection of superficial esophageal SCC was safe and efficient. Because it was associated with an increased recurrence-free survival rate, ESD should be preferred over EMR. For tumors with infiltration depths ≥ m3, chemoradiotherapy reduced the risk of nodal or distal metastasis.

Identifiants

pubmed: 30261535
doi: 10.1055/a-0732-5317
doi:

Types de publication

Clinical Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

298-306

Commentaires et corrections

Type : CommentIn

Informations de copyright

© Georg Thieme Verlag KG Stuttgart · New York.

Déclaration de conflit d'intérêts

None

Auteurs

Arthur Berger (A)

Department of Hepatology and Gastroenterology, Angers University, Angers Teaching Hospital, Angers, France.

Gabriel Rahmi (G)

Department of Gastroenterology, Georges Pompidou European Hospital, Paris, France.

Guillaume Perrod (G)

Department of Gastroenterology, Georges Pompidou European Hospital, Paris, France.

Mathieu Pioche (M)

Department of Hepatology and Gastroenterology, Lyon 1 University Claude Bernard, Edouard Herriot hospital, Lyon, France.

Jean-Marc Canard (JM)

Department of Gastroenterology, Georges Pompidou European Hospital, Paris, France.
Department of Hepatogastroenterology, Trocadero Private Hospital, Paris, France.

Elodie Cesbron-Métivier (E)

Department of Hepatology and Gastroenterology, Angers University, Angers Teaching Hospital, Angers, France.

Jérôme Boursier (J)

Department of Hepatology and Gastroenterology, Angers University, Angers Teaching Hospital, Angers, France.

Elia Samaha (E)

Department of Gastroenterology, Georges Pompidou European Hospital, Paris, France.

Ariane Vienne (A)

Department of Gastroenterology, Georges Pompidou European Hospital, Paris, France.

Vincent Lépilliez (V)

Department of Hepatogastroenterology, Mermoz Private Hospital, Lyon, France.

Christophe Cellier (C)

Department of Gastroenterology, Georges Pompidou European Hospital, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH